Literature DB >> 19688129

Association of single nucleotide polymorphisms in PIM-1 gene with the risk of Korean lung cancer.

Dae Sik Kim1, Jae Sook Sung, Eun Soon Shin, Jeong-Seon Ryu, In Keun Choi, Kyong Hwa Park, Yong Park, Eui Bae Kim, Seh Jong Park, Yeul Hong Kim.   

Abstract

PURPOSE: The expression of the PIM-1 gene, which is a proto-oncogene that encodes a serine/threonine kinase, is associated with multiple cellular functions such as proliferation, differentiation, apoptosis and tumorigenesis. In particular, several studies have reported that the PIM-1 gene is associated with the development of lymphoma, leukemia and prostate cancer. Therefore, this study was conducted to evaluate the association between the single nucleotide polymorphisms in the PIM-1 gene and the risk of lung cancer occurrence in the Korean population.
MATERIALS AND METHODS: To evaluate the role of the PIM-1 gene in the development of lung cancer, the genotypes of the PIM-1 gene were determined in 408 lung cancer patients and 410 normal subjects.
RESULTS: We found that the T-C-T-C haplotypes of the PIM-1 gene (-1196 T>C, IVS4 +55 T>C, IVS4 +1416 T>A and +3684 C>A) were associated with an increased risk of lung cancer [adjusted odds ratio (aOR): 3.98; 95% CI: 1.24 approximately 12.75, p-value: 0.020]. In particular, these haplotypes showed an increased risk of lung cancer in males (aOR: 5.67; 95% CI: 1.32~24.30, p-value: 0.019) and smokers (aOR: 7.82; 95% CI: 1.75 approximately 34.98, p-value: 0.007).
CONCLUSIONS: The present results suggest that the T-C-T-C haplotype of the PIM-1 gene could influence the risk of developing smoking-related lung cancer in the Korean population. Additional functional studies with an larger sample sized analysis are warranted to reconfirm our findings.

Entities:  

Keywords:  Haplotypes; Lung neoplasms; Oncogenes; PIM; PIM-1; SNP; Single Nucleotide Polymorphism

Year:  2008        PMID: 19688129      PMCID: PMC2697471          DOI: 10.4143/crt.2008.40.4.190

Source DB:  PubMed          Journal:  Cancer Res Treat        ISSN: 1598-2998            Impact factor:   4.679


  25 in total

Review 1.  Pim-1: a serine/threonine kinase with a role in cell survival, proliferation, differentiation and tumorigenesis.

Authors:  Z Wang; N Bhattacharya; M Weaver; K Petersen; M Meyer; L Gapter; N S Magnuson
Journal:  J Vet Sci       Date:  2001-12       Impact factor: 1.672

2.  Parallel genotyping of over 10,000 SNPs using a one-primer assay on a high-density oligonucleotide array.

Authors:  Hajime Matsuzaki; Halina Loi; Shoulian Dong; Ya-Yu Tsai; Joy Fang; Jane Law; Xiaojun Di; Wei-Min Liu; Geoffrey Yang; Guoying Liu; Jing Huang; Giulia C Kennedy; Thomas B Ryder; Gregory A Marcus; P Sean Walsh; Mark D Shriver; Jennifer M Puck; Keith W Jones; Rui Mei
Journal:  Genome Res       Date:  2004-03       Impact factor: 9.043

3.  Overexpression of PIM-1 is a potential biomarker in prostate carcinoma.

Authors:  Yong Xu; Tong Zhang; Hua Tang; Shumin Zhang; Min Liu; Dalin Ren; Yuanjie Niu
Journal:  J Surg Oncol       Date:  2005-12-15       Impact factor: 3.454

Review 4.  The new World Health Organization classification of lung tumours.

Authors:  E Brambilla; W D Travis; T V Colby; B Corrin; Y Shimosato
Journal:  Eur Respir J       Date:  2001-12       Impact factor: 16.671

5.  Pim-1 protein kinase is nuclear in Burkitt's lymphoma: nuclear localization is necessary for its biologic effects.

Authors:  Yurij Ionov; Xuan Le; Brian J Tunquist; John Sweetenham; Traci Sachs; John Ryder; Thomas Johnson; Michael B Lilly; Andrew S Kraft
Journal:  Anticancer Res       Date:  2003 Jan-Feb       Impact factor: 2.480

6.  Global cancer statistics, 2002.

Authors:  D Max Parkin; Freddie Bray; J Ferlay; Paola Pisani
Journal:  CA Cancer J Clin       Date:  2005 Mar-Apr       Impact factor: 508.702

7.  Putative association of the single nucleotide polymorphisms in RASSF1A promoter with Korean lung cancer.

Authors:  Jae Sook Sung; Sle Gi Lo Han; Young Mi Whang; Eun Soon Shin; Jae Won Lee; Hyo Jung Lee; Jeong-Seon Ryu; In Keun Choi; Kyong Hwa Park; Jun Suk Kim; Sang Won Shin; Elizabeth K Chu; Yeul Hong Kim
Journal:  Lung Cancer       Date:  2008-03-04       Impact factor: 5.705

8.  National cancer incidence for the year 2002 in Korea.

Authors:  Hai-Rim Shin; Kyu-Won Jung; Young-Joo Won; Hyun-Joo Kong; Seon-Hee Yim; Joohon Sung; Sun-Won Seo; Ki-Young Kim; Sang-Yi Lee; In-Sik Kong; In Kyoung Hwang; Choong Won Lee; Ze-Hong Woo; Tae-Yong Lee; Jin-Su Choi; Cheol-In Yoo; Jong-Myon Bae; Keun-Young Yoo
Journal:  Cancer Res Treat       Date:  2007-12-31       Impact factor: 4.679

9.  Aberrant expression of serine/threonine kinase Pim-3 in hepatocellular carcinoma development and its role in the proliferation of human hepatoma cell lines.

Authors:  Chifumi Fujii; Yasunari Nakamoto; Peirong Lu; Koichi Tsuneyama; Boryana K Popivanova; Shuichi Kaneko; Naofumi Mukaida
Journal:  Int J Cancer       Date:  2005-03-20       Impact factor: 7.396

10.  Increased expression of the hPim-2 gene in human chronic lymphocytic leukemia and non-Hodgkin lymphoma.

Authors:  Amos M Cohen; Borislava Grinblat; Hanna Bessler; Donald Kristt; Alona Kremer; Ariel Schwartz; Marisa Halperin; Sarah Shalom; Drorit Merkel; Jeremy Don
Journal:  Leuk Lymphoma       Date:  2004-05
View more
  6 in total

1.  Expressions of Osteopontin (OPN), ανβ3 and Pim-1 Associated with Poor Prognosis in Non-small Cell Lung Cancer (NSCLC).

Authors:  Yi Jin; Da-Yue Tong; Lu-Ying Tang; Jian-Ning Chen; Jing Zhou; Zhi-Ying Feng; Chun-Kui Shao
Journal:  Chin J Cancer Res       Date:  2012-06       Impact factor: 5.087

2.  PIM1 polymorphism and PIM1 expression as predisposing factors of esophageal squamous cell carcinoma in the Asian population.

Authors:  Yuan-Bo Wu; Di Lu; Zhi-Feng He; Chan-Guan Jin
Journal:  Onco Targets Ther       Date:  2016-05-17       Impact factor: 4.147

3.  HistoneH3 demethylase JMJD2A promotes growth of liver cancer cells through up-regulating miR372.

Authors:  Jiahui An; Jie Xu; Jiao Li; Song Jia; Xiaonan Li; Yanan Lu; Yuxin Yang; Zhuojia Lin; Xiaoru Xin; Mengying Wu; Qidi Zheng; Hu Pu; Xin Gui; Tianming Li; Dongdong Lu
Journal:  Oncotarget       Date:  2017-07-25

4.  Loss of PIM1 correlates with progression and prognosis of salivary adenoid cystic carcinoma (SACC).

Authors:  Jiajie Xu; Xin Zhu; Qingling Li; Chao Chen; Zhenying Guo; Zhuo Tan; Chuanming Zheng; Minghua Ge
Journal:  Cancer Cell Int       Date:  2018-02-20       Impact factor: 5.722

5.  Overexpression of osteopontin, αvβ3 and Pim-1 associated with prognostically important clinicopathologic variables in non-small cell lung cancer.

Authors:  Yi Jin; Da-yue Tong; Jian-ning Chen; Zhi-ying Feng; Jian-yong Yang; Chun-kui Shao; Jia-ping Li
Journal:  PLoS One       Date:  2012-10-31       Impact factor: 3.240

Review 6.  PIM Kinase as an Executional Target in Cancer.

Authors:  Xinning Zhang; Mengqiu Song; Joydeb Kumar Kundu; Mee-Hyun Lee; Zhen-Zhen Liu
Journal:  J Cancer Prev       Date:  2018-09-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.